Phase II Bisantrene trial data published in European Journal of Haematology
10 November 2020 – Race Oncology Limited (ASX: RAC) is pleased to report that the…
Welcome to our Investor page. Here you will find information on the latest ASX announcements, investor presentations and other shareholder information on Race Oncology.
ASX Announcements
Share Price
Latest News
Phase II Bisantrene trial data to be presented at ASH 2020
5 November 2020 – Race Oncology Limited (ASX: RAC) is pleased to report that the…
Prof. Borje S. Andersson appointed Chief Medical Officer
Race Oncology Limited is pleased to announce that Professor Borje S. Andersson has agreed to…
Race appoints clinical and FDA regulatory strategy advisor
Race Oncology is pleased to announce that it has appointed the clinical and regulatory strategy…
Race team talks about new leadership model
Our executive leaders discuss the benefits of a shared leadership model and the experience they…
Race leadership team strengthened
1 September 2020 – Race Oncology Limited (ASX: RAC) is pleased to announce that it…
